Tag: Breast Cancer,NSCLC,Press Releases,Veristrat,blood-based cancer test,cancer diagnostics,lapatinib,letrozole,liquid biopsy,molecular diagnostic,oncology,personalized medicine
-
VeriStrat® Test Predicts Outcomes in Advanced Breast Cancer Patients
Results from the VeriStrat retrospective analysis of the Phase III trial, EGF30008, were presented today at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. The EGF30008 study compared Femara® plus placebo to Femara plus Tykerb® in 1st line, hormone receptor positive, advanced breast cancer patients. The study included both Her2 positive and Her2 negative patients. Results…